Yali Qu
- Topics
- Liver Disease Diagnosis and Treatment (5 papers)Hepatocellular Carcinoma Treatment and Prognosis (3 papers)COVID-19 Clinical Research Studies (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yali Qu
19 papers receiving 238 citations
Peers
Comparison fields: 5 of 52
- Epidemiology 76
- Infectious Diseases 57
- Radiology, Nuclear Medicine and Imaging 47
- Hepatology 43
- Oncology 41
Countries citing papers authored by Yali Qu
This map shows the geographic impact of Yali Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yali Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yali Qu more than expected).
Fields of papers citing papers by Yali Qu
This network shows the impact of papers produced by Yali Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yali Qu. The network helps show where Yali Qu may publish in the future.
Co-authorship network of co-authors of Yali Qu
This figure shows the co-authorship network connecting the top 25 collaborators of Yali Qu. A scholar is included among the top collaborators of Yali Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yali Qu. Yali Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 22 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 7 | |
| 7 | 17 | |
| 8 | 7 | |
| 9 | 13 | |
| 10 | 6 | |
| 11 | 32 | |
| 12 | 10 | |
| 13 | 48 | |
| 14 | 7 | |
| 15 | 26 | |
| 16 | 26 | |
| 17 | [Epidemiological status and risk factors of hyperuricemia in rural area of the Three Gorges]. | 6 |
| 18 | [Type 2 diabetes prevalence and its risk factors among migrants and nonmigrants aged 35 years and older in Three Gorge Dam area, China]. | 1 |
| 19 | 7 |
About Yali Qu
Yali Qu is a scholar working on Health Informatics, Hepatology and Nephrology, having authored 19 papers that have together received 240 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and COVID-19 Clinical Research Studies (3 papers). The work is most often cited by research in Internal Medicine (28 citations), Hepatology (43 citations) and Infectious Diseases (57 citations). Yali Qu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Bin Song, Mou Li, Yingzhen Zhang, Gavin Hamilton, Qingyang Huang, Bing‐Xin Lei, Yu Wang, Ruiting Li, Yu Yuan and Huaqing Shu. Their work appears in journals such as PLoS ONE, Scientific Reports and Journal of Affective Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.